Company news

Anagenics Limited news in 2018

Anagenics Limited's news releases, calls and decks from 2018, newest first.

View company

Cellmid Expects Record Sales in Q2 FY2019

December 11, 2018

Cellmid Appoints Exclusive New Zealand Distributor

November 18, 2018

New Patents for Midkine Antibodies in USA and Europe

November 6, 2018

Ikon Legal Action - Decision

November 2, 2018

Cellmids Evolis Successfully Launched in USA stores

October 31, 2018

Change of Registry Address: Automic P/L - Sydney Office

September 28, 2018

Lead Antibody Effective in Rare Chronic Kidney Disease

September 12, 2018

Cellmid Share Purchase Plan Completion

September 2, 2018

Evolis USA Distribution Update

August 30, 2018

Preliminary Final Report

August 24, 2018

Cleansing Notice and Appendix 3B

August 6, 2018

Cellmid Share Purchase Plan

July 31, 2018

Cellmid Share Placement Raises $9M

July 30, 2018

Cellmid updates on distribution of evolis

July 10, 2018

Cellmid to commence selling of evolis into Chinese market

May 2, 2018

Cellmid secures Bloomingdales USA partnership for evolis

April 23, 2018

Appendix 4C - quarterly

April 22, 2018

Cellmid signs distribution agreement for fillerina

April 4, 2018

Appendix 4D and Half Year Accounts

February 21, 2018

Record 2M sales for Cellmid FGF5 inhibitors

January 9, 2018

Cellmid quarterly operational update

January 8, 2018

Decks in 2018